Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.
2 reports, 2 independent
Updated Sep 27
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments from firms including Citigroup, Morgan Stanley, and Truist Financial.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Scotiabank reduced its target price on Vornado shares, and Citigroup increased its price objective.1 source
Analyst coverage for Vornado Realty Trust resulted in rating changes and price target adjustments.1 source
Keep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Morgan Stanley
U.S. investment bank
- Morgan Stanley increased its price target for SLM Corporation on September 2, 2026.
- An offering was filed with the SEC on July 22, 2025, involving Simmons Bank, with joint book-running management from Stephens Inc., Keefe, Bruyette & Woods, and Morgan Stanley, and co-management from Robert W. Baird & Co.
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
-
Vornado Realty Trust
company
Nothing else this week.
Related events
- Citigroup raised its price target and gave a buy rating for International Paper, with MarketBeat providing consensus data.
- Amphenol received multiple analyst upgrades and target price increases from firms including Citigroup, Bank of America, and Jefferies Financial Group on July 9, 2026.
- Truist Financial analysts dropped the target price for Deckers Outdoor on July 24, 2026.
- Rating firms Raymond James Financial, Truist Financial, and CIBC have issued updates regarding Weyerhaeuser, including target price setting and rating changes.
- Citigroup, Morgan Stanley, and TD Cowen have raised their price targets and upgraded ratings for Royalty Pharma, with filings made public via the SEC.